Loading clinical trials...
Loading clinical trials...
Effectiveness of Telerehabilitation in Continuity With Outpatient Physiotherapy After Total Hip Replacement: Randomized Clinical Trial.
Total arthroplasty (THA) is the treatment of choice for severe osteoarthritis of the hip joint. Following this type of intervention, a multidisciplinary rehabilitation approach allows you to reduce pain and improve the ability to carry out activities of daily living (ADL), but it is not clear what the optimal rehabilitation program is. Recently, the use of telerehabilitation has increased over the years. Specifically, in treatment of patients following THA surgery, telerehabilitation is able to give similar results to the treatment performed in person terms of pain and function. The aim of this study is to verify whether telerehabilitation associated with In-person treatment is comparable in terms of pain, recovery functionality and patient participation and satisfaction, compared to those provided by rehabilitation alone in the presence of patients undergoing THA surgery.
Age
50 - 80 years
Sex
ALL
Healthy Volunteers
No
IRCCS Istituto ortopedico Rizzoli
Bologna, Italia, Italy
Start Date
February 10, 2024
Primary Completion Date
November 10, 2026
Completion Date
December 10, 2026
Last Updated
February 23, 2026
104
ESTIMATED participants
Telerehabilitation
OTHER
Traditional rehabilitation
OTHER
Lead Sponsor
Istituto Ortopedico Rizzoli
NCT06593678
NCT07094737
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions